ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease

Diabetes Research and Clinical Practice

Volumn 64, Issue 1, 2004, Pages 41-49

  Sakka, Yumiko ^a   Babazono, Tetsuya ^a   Sato, Asako ^a   Ujihara, Noriko ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme (ACE) gene polymorphism; Diabetic nephropathy; End stage renal disease; Left ventricular hypertrophy; Relative wall thickness

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BIOSAFETY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; GEOMETRY; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PERFORMANCE; SURVIVAL RATE;

EID: 1342345223     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.10.010     Document Type: Article

References (47)

1. U.S. Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.
2. Nakai S., Shinzato T., Sanaka T.et al. The current state of chronic dialysis treatment in Japan (as of 31 December 2000). J. Jpn. Soc. Dial. Ther. 35:2002;1155-1184.
3. Ritz E., Strumpf C., Katz F., Wing A.J., Quellhorst E. Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension. 7(6 (Pt. 2)):1985;118-124.
4. Collins A.J., Hanson G., Umen A., Kjellstrand C., Keshaviah P. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am. J. Kidney. Dis. 15:1990;422-432.
5. Harnett J.D., Parfrey P.S., Griffiths S.M., Gault M.H., Barre P., Guttmann R.D. Left ventricular hypertrophy in end-stage renal disease. Nephron. 48:1988;107-115.
6. Ma K.W., Greene E.L., Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am. J. Kidney Dis. 19:1992;505-513.
7. Stack A.G., Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am. J. Kidney Dis. 40:2002;1202-1210.
8. Grossman E., Shemesh J., Shamiss A., Thaler M., Carroll J., Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch. Intern. Med. 152:1992;1001-1004.
9. Gambardella S., Frontoni S., Spallone V.et al. Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am. J. Hypertens. 6:1993;97-102.
10. Thuesen L., Christiansen J.S., Mogensen C.E., Henningsen P. Echocardiographic-determined left ventricular wall characteristics in insulin-dependent diabetic patients. Acta Med. Scand. 224:1988;343-348.
11. Sato A., Tarnow L., Parving H.-H. Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy. Diabetologia. 42:1999;76-80.
12. Adams T.D., Yanowitz F.G., Fisher A.G. Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation. 71:1985;39-44.
13. Verhaaren H.A., Schieken R.M., Mosteller M., Hewitt J.K., Eaves L.J., Nance W.E. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am. J. Cardiol. 68:1991;661-668.
14. Schunkert H., Hense H.-W., Holmer S.R.et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330:1994;1634-1638.
15. Lindpaintner K., Lee M., Larson M.G.et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N. Engl. J. Med. 334:1996;1023-1028.
16. Lechin M., Quinones M.A., Omran A.et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
17. Osono E., Kurihara S., Hayama N.et al. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am. J. Kidney Dis. 32:1998;725-730.
18. Nagahara T., Ishigami T., Sano T. Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis patients. Jpn. Heart J. 38:1997;821-830.
19. Yildiz A., Akkaya V., Hatemi A.C.et al. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron. 84:2000;130-135.
20. Marre M., Bernadet P., Gallois Y.et al. Relationships between angiotensin I converting enzyme gene polymorphism. Diabetes. 43:1994;384-388.
21. Schmidt S., Schone N., Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 47:1995;1176-1181.
22. Tarnow L., Cambien F., Rossing P.et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 44:1995;489-494.
23. Tomino Y., Makita Y., Shike T.et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron. 82:1999;139-144.
24. Miura J., Uchigata Y., Yokoyama H., Omori Y., Iwamoto Y. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res. Clin. Pract. 45:1999;41-49.
25. Palmer B.R., Pilbrow A.P., Yandle T.G.et al. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. J. Am. Colloid Cardiol. 41:2003;729-736.
26. Losito A., Parente B., Cao P.G., Jeffery S., Afzal A.R. ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am. J. Kidney Dis. 35:2000;211-215.
27. Higashiuesato Y., Tana T., Tozawa M.et al. Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients. Clin. Nephrol. 58:2002;370-375.
28. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55:1977;613-618.
29. Savage D.D., Garrison R.J., Kannel W.B.et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham study. Circulation. 75(1):1987;26-33.
30. R.B. Devereux, M.J. Roman, Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques, in: J.H. Laragh, B.M. Brenner (Eds.), Hypertension: Pathophysiology, Diagnosis, Treatment, second ed. Raven Press, New York, 1995, pp. 1969-1985.
31. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left ventricular mass and geometry to morbidity in uncomplicated essential hypertension. Ann. Intern. Med. 114:1991;345-352.
32. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res. 20:1992;1433.
33. Babazono T., Tomonaga O., Yano K.et al. Continuous ambulatory peritoneal dialysis (CAPD) in diabetic patients: five-year's experience at a single institute (Abstract). Perit. Dial. Int. 11:1993;A23.
34. B.H. Margolin, Test for trend in proportions, in: S. Klotz, N.L. Johnson (Eds.), Encyclopedia of Statistical Sciences, vol. 9, New York, Wiley, 1988, pp. 334-336.
35. Higaki J., Baba S., Katsuya T.et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: The Suita Study. Circulation. 101:2000;2060-2065.
36. Matsubara M., Suzuki M., Fujiwara T.et al. Angiotensin-converting enzyme I/D polymorphism and hypertension: The Ohasama study. J. Hypertens. 20:2002;1121-1126.
37. Gohda T., Makita Y., Shike T.et al. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin. Nephrol. 56:2001;475-480.
38. Cambien F., Poirier O., Lecerf L.et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
39. Prasad N., O'Kane K.P., Johnstone H.A.et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. QJM. 87:1994;659-662.
40. Gharavi A.G., Lipkowitz M.S., Diamond J.A., Jhang J.S., Phillips R.A. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am. J. Cardiol. 77:1996;1315-1319.
41. Anonymous: Freely Associating, Nat. Genet. 22 (1999) 1-2.
42. Grimm R., Rettig R. Association studies between the angiotensin- converting enzyme insertion/deletion polymorphism and hypertension: still interesting. J. Hypertens. 20:2002;1049-1051.
43. London G.M. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin. Dial. 16:2003;85-94.
44. Foley R.N. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin. Dial. 16:2003;111-117.
45. Harden P.N., Geddes C., Rowe P.A.et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet. 345:1995;1540-1542.
46. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am. J. Kidney Dis. 15:1990;458-482.
47. Owen W.F. Jr., Lew N.L., Liu Y., Lowrie E.G., Lazarus J.M. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N. Engl. J. Med. 329:1993;1001-1006.